Actinium Pharmaceuticals, Inc. (ATNM)

1.06 -0.05 (-4.50%) USD  |  NYAM  |  Feb 20, 16:00
1.065 0.00 (0.00%) After-Hours: 20:00
More

Actinium Pharmaceuticals SG&A Expense (Quarterly) : 1.534M for Sept. 30, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for ATNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Assertio Holdings, Inc. 10.74M
Altimmune, Inc. 5.904M
Aldeyra Therapeutics, Inc. 2.570M
Avanos Medical, Inc. 77.60M
ACADIA Pharmaceuticals, Inc. 133.40M